Associates in Medical Physics (AMP)
Associates in Medical Physics (AMP) strives to provide the highest quality professional services to hospitals, clinics, and healthcare systems. Using medical and industrial radiation applications, we offer technical expertise for consultation, development, and management of applied radiation systems, including staffing and management solutions. AMP seeks out programs where we can augment and partner for great patient care.
Best Medical International now encompasses a family of trusted companies and organizations with a proven track record of innovation, quality and service in external beam radiation therapy, brachytherapy and vascular brachytherapy solutions. Our aim is to be the one partner that clinicians turn to for all their radiotherapy and oncology product and service requirements. TeamBest® can provide all your needs under one purchase order for external beam therapy and brachytherapy including:
Augmenix was recently acquired by Boston Scientific. SpaceOAR™ hydrogel is now a member of the prostate health family of products within Boston Scientific. SpaceOAR hydrogel provides over 1 cm of space between the prostate and rectum to decrease rectal toxicity and minimize changes in quality of life (QOL) following prostate radiotherapy.
C4 Imaging LLC
C4 Imaging develops innovative medical devices that enable clinicians to personalize patient treatment through accurate MRI guided procedures. LDR post-implant seed localization is achieved with the Sirius™ MRI Marker, along with a new MRI line marker for HDR planning. The company's core proprietary technology, C4, is a unique magnetic resonance imaging (MRI) agent that is encapsulated within a biocompatible shell.
CIVCO Radiotherapy has over 35 years of experience in the radiation oncology industry and offers the largest breadth of high-quality, innovative, patient-centric radiotherapy solutions. These solutions include couchtops and overlays for linear accelerators and imaging systems, advanced patient immobilization solutions, robotic patient positioning, advanced fiducial markers, and immobilization/positioning equipment and consumables.
Concure Oncology | Breast Microseed Inc.
Concure Oncology’s Breast Microseed Treatment® delivers a one-time, one-hour form of APBI in the post-lumpectomy setting when final pathology is known and without the scheduling challenges associated with having both surgeon and radiation oncologist in the OR simultaneously. With excellent published clinical outcomes, Breast Microseed Treatment® allows for the precise placement of tiny Palladium seeds to deliver a targeted, tumoricidal dose of radiation to the area at greatest risk for recurrence, sparing healthy tissue. Importantly, published studies confirm that the heart and lungs receive an imperceptible dose as compared to other forms of APBI. This one and done, clinically effective Breast Microseed Treatment® allows women to quickly move on with their lives.
Elekta pioneers significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, stateo-f-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.
Encompassing forty years innovation, Elekta's brachytherapy solutions are designed for precise, targeted treatment of various cancers such as prostate, breast, skin and surface, rectum and gynecological anatomy. The best-in-class clinical solutions include Flexitron® afterloading, Oncentra® Brachy treatment planning, Esteya® electronic brachytherapy, the broadest range of applicators in the industry and Real-time Prostate Solutions. To learn more, visit www.elekta.com/brachytherapy.
As the manufacturer of Advantage™ I-125 and Pd-103 seeds for over 15 years, IsoAid specializes in providing brachytherapy seeds for the treatment of prostate, ocular and breast cancer, as well as for diagnostic localization purposes. We are a full-service company you can always rely on, making seeds at the activity you request, custom-loading and delivering them faster than anyone in the industry. Through our exclusive partnership with Eye Physics we give you access to cutting edge eye plaques and planning services, which deliver many clinical advantages to you and your patients. High-activity seeds are custom-loaded using COMS or Eye Physics plaques. Our innovate Secure Strand™, cuts down significantly on migration for prostate patients and is now being used for RSL with great success. Our team of experts is dedicated to helping with every aspect of your program and serves as a complete resource for you. IsoAid is invested in the future of Brachytherapy and we look forward to introducing you to some exciting new advances very soon.
Isoray Medical passionately designs and develops innovative and personalized brachytherapy products that effectively treat many forms of cancer. We believe in pioneering solutions for life beyond your cancer.
Founded in 1998 to explore the medical use of Cesium 131 for the treatment of prostate cancer, Isoray's low dose rate (LDR) brachytherapy product was cleared by the FDA for treatment of various cancers. Since the first patient was treated with Isoray's Cesium product in October 2004, Isoray has provided products for over 10,000 patient treatments, including prostate cancer, brain, head & neck and gynecological tumors, and other isolated tumors and tumor beds.
Isoray has a dedicated team of employees who passionately work together to design, develop, produce and deliver products to address clinical needs and push the industry status quo with highly efficacious and patient-centric treatments.
Janssen Biotech, Inc
Qfix is an innovative medical device company focused on discovering, developing and commercializing technology-driven solutions that are compatible in modalities ranging from linear accelerators, proton therapy, and imaging technologies. Qfix's primary focus is designing patient positioning and immobilization solutions that meet the unique physics of photon and proton beam transmission and allow for high precision treatment through reduced intra- and inter-fraction patient movement. We advance precise positioning solutions for cancer treatment by fostering a deep engagement with medical professionals. With the learning and relationships built from these deep ties, we are aggressively pursuing many cutting edge solutions, including Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Magnetic Resonance (MR) and Patient Transport. Log on to www.Qfix.com for more information.
Revenue Cycle Coding Strategies
From audit preparation and process improvement to billing services and training, the combined teams of Revenue Cycle Coding Strategies and RC Billing have been creating success stories in oncology operations and administration for more than 30 years. Turn to our oncology experts to identify ways to streamline reimbursement, cut operational costs, maintain compliance, and improve profitability.
Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. The recently introduced Sculptura™ robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently.
Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.
As an industry pioneer and leader, Theragenics has an unparalleled history of > 35 years in the manufacture and global supply of low-dose rate (LDR) brachytherapy seeds for the treatment of prostate cancer, lung cancer, intra-ocular malignancies, benign disease, and other solid tumors. Theragenics continues to invest and develop innovative brachytherapy solutions, supported by the recent launch of Orion™, a novel, positive-signal MRI marker for HDR treatment planning. Please contact us to learn more about our industry benchmark recognized sources TheraSeed® Pd-103 & AgX100® I-125, and Orion MRI HDR Line Marker.
Varian Medical Systems
Varian Medical Systems focuses energy on saving lives by equipping the world with advanced technology for fighting cancer. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. For more information, visit www.varian.com/brachytherapy.